**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1309-60-0 |Lead (IV) Oxide, P.A. | | 215-174-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 20/22 33 61 62
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. May cause harm to the unborn child. Possible risk of
impaired fertility.Oxidizer.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause kidney damage.
Inhalation:
Causes respiratory tract irritation. May cause effects similar to
those described for ingestion.
Chronic:
Chronic exposure to lead may result in plumbism which is
characterized by lead line in gum, headache, muscle weakness, mental
changes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Antidote:
The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating
agent should be determined by qualified medical personnel. The use of
Calcium disodium EDTA as a chelating agent should be determined by
qualified medical personnel. The use of d-Penicillamine as a
chelating agent should be determined by qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Combustion generates toxic fumes. Strong oxidizer.
Contact with other material may cause fire. During a fire,
irritating and highly toxic gases may be generated by thermal
decomposition or combustion. Runoff from fire control or dilution
water may cause pollution.
Extinguishing Media:
Use water only!
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up or absorb material, then place into a
suitable clean, dry, closed container for disposal. Avoid generating
dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Keep from contact with clothing and other combustible
materials.
Storage:
Do not store near combustible materials. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 1309-60-0:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level (
Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani
compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: dark brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 290 deg C ( 554.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 290 deg C
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: O2Pb
Molecular Weight: 239.19
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, combustible materials, reducing agents,
strong oxidants.
Incompatibilities with Other Materials:
Aluminum carbide, barium sulfide, boron calcium sulfide,
cesium,acetylene, carbide, chlorine trifluoride, hydrogen peroxide,
hydrogen sulfide, hydroxylamine, molybdenum, peroxyformic acid,
phenyl hydrazine, phosphorus, phosphorus trichloride, sulfur,
sulfuryl chloride, tungsten and zirconium.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1309-60-0: OG0700000
LD50/LC50:
Not available.
Carcinogenicity:
Lead (IV) Oxide, P.A. -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: LEAD DIOXIDE
Hazard Class: 5.1
UN Number: 1872
Packing Group: III
IMO
Shipping Name: LEAD DIOXIDE
Hazard Class: 5.1 (6.1)
UN Number: 1872
Packing Group: III
RID/ADR
Shipping Name: LEAD DIOXIDE
Hazard Class: 5.1
UN Number: 1872
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1309-60-0: 0
Canada
CAS# 1309-60-0 is listed on Canada's DSL List.
CAS# 1309-60-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1309-60-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/06/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Methylcyclopropanecarboxylic Acid, 98%
| 29555-02-0 |
|
m-Phenylene diisocyanate
| 123-61-5 |
|
2-Dodecanol, 99%
| 10203-28-8 |
|
Oxalic Acid Bis(Benzylidenehydrazide), 97% (UV-Vis)
| 6629-10-3 |
|
5-Bromopyrimidine, 98%
| 4595-59-9 |
|
4,6-Diamino-2-Mercaptopyrimidine, Hemihydrate, 99%
| 1004-39-3 |
|
4-(4'-Aminophenylazo)-Phenylarsonic Acid
| 6966-64-9 |
|
2,4-Dicyano-3-Methylglutaramide, 99%
| 5447-66-5 |
|
Ethyl trimethylacetate, 98%
| 3938-95-2 |
|
2-Mercapto-4-methylpyrimidine hydrochloride, 99%
| 6959-66-6 |
|
1-Pyrrolidinecarboxaldehyde, 97%
| 3760-54-1 |
|
n-Methyleneglycinonitrile (trimer)
| 6865-92-5 |
|
5-Methoxytryptamine hydrochloride, 97%
| 66-83-1 |
|
Nifuroxime
| 555-15-7 |
|
N-Alpha-Acetyl-L-Histidine Monohydrate 99+%
| 39145-52-3 |
|
11-Bromoundecanoic acid, tech., 93%
| 2834-05-1 |
|
Tert.-Butyl Disulfide, 98%
| 110-06-5 |
|
4'-Dodecyloxyacetophenone, 94% (GC)
| 2175-80-6 |
|
Ethylmagnesium chloride, 25 wt% solution in tetrahydrofuran
| 109-99-9 |
|
Methyl Vinyl Ether/Maleic Acid Copolymer, Low Molecular Weight
| 25153-40-6 |
|
Chlorohydroquinone, tech., 90%
| 615-67-8 |
|
Tri-n-octylphosphine oxide, 97%
| 78-50-2 |
|
Silver proteinate (mild)
| 9008-42-8 |
|
Lead (IV) Oxide, P.A.
| 1309-60-0 |
|
1,4-Butane Sultone, 99+%
| 1633-83-6 |
|
4-Chloro-3-Iodobenzotrifluoride, 99%
| 672-57-1 |
|
Theophylline, Anhydrous, U.S.P./N.F.
| 58-55-9 |
|
P-Anisoyl Chloride, 99%
| 100-07-2 |
|
3-Carboxy-1,4-dimethyl-1h-pyrrole-2-acetic acid
| 33369-45-8 |
|
4-Amino-2,6-dichlorophenol, 98%
| 5930-28-9 |
|
Aminoguanidine Hemisulfate
| 996-19-0 |
|
N-Methylmorpholine hydrochloride, 99+%
| 3651-67-0 |
|
2-Chloro-4,6-dimethoxy-1,3,5-triazine, 98%
| 3140-73-6 |
|
1-Heptyne, 99%
| 628-71-7 |
|
(R)-(+)-2,2'-Bis(diphenylphosphino)- 1,1'-binaphthyl, 99+%
| 76189-55-4 |
|
2-Propene-1-Sulfonic Acid Sodium Salt (Pract)
| 2495-39-8 |
|
6-Amino-1-Hexanol, 94%
| 4048-33-3 |
|
2,5-Dibromonitrobenzene, 97%
| 3460-18-2 |
|
Rubidium Fluoride Hydrate, 99+%
| 16422-67-6 |
|
7-Chloro-2H-1,4-Benzothiazin-3(4H)-One,99%
| 5333-05-1 |
|
2-Methyl-2-Nitropropane, 99%
| 594-70-7 |
|
N-Ethyl-n-butylamine, 99%
| 13360-63-9 |
|
2,6-Dimethylaniline, 99%
| 87-62-7 |
|
2-Chloro-3-Methylquinoline, 97%
| 57876-69-4 |
|
3-Cyanobenzaldehyde, 99%
| 24964-64-5 |
|
N,N'-Diallyltartardiamide, 99+%
| 28843-34-7 |
|
3-Aminobenzonitrile, 99%
| 2237-30-1 |
|
2-Chloropyridine-n-oxide hydrochloride, 97%
| 20295-64-1 |
|
Sodium perchlorate
| 7601-89-0 |
|
Butadiene sulfone, 98%
| 77-79-2 |
|
|